Grants Search Results

Relapsed pediatric acute lymphoblastic leukemia is best treated by allogeneic stem cell transplant, including cord blood transplant. The significant number of children with persistent leukemia prior to transplant are at increased risk of post-transplant relapse and poor survival. As the Georgia and the Peachy Keens Hero Fund St. Baldrick's Fellow, Dr. Summers is working to prevent relapse by engineering cord blood donor T cells to target leukemia. The engineered T cells are infused following transplant to kill residual leukemia. This research aims to demonstrate that these cells are functional in eliminating leukemia.

A portion of the grant was named for the Georgia and the Peachy Keens Hero Fund created in honor of Georgia Moore and celebrates the 5th year past her cancer diagnosis. As a leukemia survivor, she inspires others to "just keep swimming" in raising awareness, hope, and research dollars.

Ewing sarcoma is a type of cancer that mostly affects children and your adults. This cancer is caused by a type of mutation in DNA called a translocation. Dr. Sweet-Cordero's Team Clarkie St. Baldrick's Research Grant aims to understand how this translocation, called EWS-FLI1, causes cancer in order to find better therapies for children with this disease.

This grant is named for the Team Clarkie Fund created to honor Clarkie Carroll and funds Ewing’s sarcoma research while stimulating greater awareness and inspiring others to believe pediatric cancer research can and will lead to a cure.

Medulloblastoma is the most aggressive brain tumor in children. Finding new therapies depends upon a better understanding of the biological mechanisms of medulloblastoma formation. As the recipient of the Hannah's Heroes St. Baldrick's Research Grant, Dr. Van Meir is evaluating the role of a tumor suppressor in medulloblastoma tumorigenesis. Understanding the role of this suppressor could lead to novel therapeutic prospects for children with medulloblastoma.

This grant is named for the Hannah's Heroes Hero Fund created in honor of Hannah Meeson and pays tribute to her fight by raising awareness and funding for all childhood cancers.

Based on progress to date, Dr. Vasquez was awarded a new grant in 2017 to fund an additional year of this Fellow award. Dr. Vasquez, the Tap Cancer Out St. Baldrick's Fellow, is investigating the human immune system's response to pediatric brain tumors and how it can be manipulated in order to develop new treatments. Immune therapies can be highly specific for cancer cells because they target proteins only found on the cancer while sparing the normal cells. This research is using nanoparticles that contain the target protein as well as medications that block other cells that dampen the immune system in order to increase the immune system's ability to kill the cancer cells.

This grant recognizes the partnership with Tap Cancer Out, a jiu-jitsu based 501(c)(3) nonprofit raising awareness and funds for cancer fighting organizations on behalf of the grappling community.

Based on progress to date, Dr. Wasswa was awarded a new grant in 2018 to fund an additional year of this International Scholar grant. Whereas more than 80% of children with leukemia and lymphoma in the United States are cured with chemotherapy, in Africa a diagnosis with one of these diseases is an outright death sentence. To enable adaptation of chemotherapy protocols from the U.S. to treating children in Africa, Dr. Wasswa is studying the prevalent types of leukemia and lymphoma in children in Malawi and how their genetic code may affect response to chemotherapy.

Based on progress to date, Dr. Wasswa was awarded new grants in 2018 and 2019 to fund additional years of this International Scholar grant. Whereas more than 80% of children with leukemia and lymphoma in the United States are cured with chemotherapy, in Africa a diagnosis with one of these diseases is an outright death sentence. To enable adaptation of chemotherapy protocols from the U.S. to treating children in Africa, Dr. Wasswa is studying the prevalent types of leukemia and lymphoma in children in Malawi and how their genetic code may affect response to chemotherapy.

Based on progress to date, Dr. Lian was awarded new grants in 2018 and 2019 to fund additional years of this International Scholar grant. Based on progress to date, Dr. Lian was awarded a new grant in 2018 to fund an additional year of this International Scholar grant. MYCN-driven neuroblastoma accounts for about 30% of neuroblastomas and is associated with an extremely poor prognosis. Casein Kinase 2 (CK2) is an enzyme that is currently in clinical trials to treat multiple cancers. However, its efficacy on MYCN-driven neuroblastoma remains unknown. Dr. Lian's research aims to test if CK2 inhibition can serve as a new strategy to treat MYCN-driven neuroblastoma. A portion of this grant was named for The Amanda Rozman Pediatric Cancer Research Fund, a St. Baldrick's Hero Fund created in memory of Amanda Rozman and honors her courageous battle with neuroblastoma by funding promising new treatments and clinical trials in the area of translational research.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a doctoral student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty. The “Tough Like Ike St. Baldrick’s Summer Fellow” is funded by the Yarmon family whose son, Isaac is battling B-cell acute lymphoblastic leukemia and is named in honor of his courage and strength.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty. The “Tough Like Ike St. Baldrick’s Summer Fellow” is funded by the Yarmon family whose son, Isaac is battling B-cell acute lymphoblastic leukemia and is named in honor of his courage and strength.

This grant funds two medical students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds two students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a doctoral student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty. The “Tough Like Ike St. Baldrick’s Summer Fellow” is funded by the Yarmon family whose son, Isaac is battling B-cell acute lymphoblastic leukemia and is named in honor of his courage and strength.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.